Search research articles
Contact Us
Filters
Showing results (41-50 of 170) with videos related to
Page
of 17
Sort By:
Cancer
|
April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
Ben Tran, Scott Kopetz, Jeanne Tie, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
October 8, 2022
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
Clinical Trial Protocol for LuCAB: A Phase I-II Trial Evaluating Cabazitaxel in Combination with [<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
Louise Kostos, James P Buteau, Grace Kong, et al.
Therapeutic Advances in Medical Oncology
|
March 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies
Ciara Conduit, Bruno Valentin Sinn, Catherine Mitchell, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 1, 2019
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study
Francis J Ha, Lavinia Spain, Anthony Dowling, et al.
JCO Oncology Practice
|
May 28, 2024
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors
Ying Yan Zhong, Angelyn Anton, Owen Xie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 22, 2024
First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [<sup>68</sup>Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma
Michael S Hofman, Ben Tran, Darren R Feldman, et al.
Internal Medicine Journal
|
March 12, 2021
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Arun A Azad, Ben Tran, Ian D Davis, et al.
Internal Medicine Journal
|
March 1, 2019
Demonstrating the feasibility of collecting secondary, de-identified data on Australian patients receiving treatment as part of a Medicine Access Programme
Sheau W Lok, Richard De Boer, Cassandra Cordwell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2023
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies
Adel Shahnam, Nadia Hitchen, Udit Nindra, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 170) with videos related to
Sort By:
Page
of 17
Cancer
|
April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
Ben Tran, Scott Kopetz, Jeanne Tie, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
October 8, 2022
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
Clinical Trial Protocol for LuCAB: A Phase I-II Trial Evaluating Cabazitaxel in Combination with [<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
Louise Kostos, James P Buteau, Grace Kong, et al.
Therapeutic Advances in Medical Oncology
|
March 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies
Ciara Conduit, Bruno Valentin Sinn, Catherine Mitchell, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 1, 2019
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study
Francis J Ha, Lavinia Spain, Anthony Dowling, et al.
JCO Oncology Practice
|
May 28, 2024
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors
Ying Yan Zhong, Angelyn Anton, Owen Xie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 22, 2024
First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [<sup>68</sup>Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma
Michael S Hofman, Ben Tran, Darren R Feldman, et al.
Internal Medicine Journal
|
March 12, 2021
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Arun A Azad, Ben Tran, Ian D Davis, et al.
Internal Medicine Journal
|
March 1, 2019
Demonstrating the feasibility of collecting secondary, de-identified data on Australian patients receiving treatment as part of a Medicine Access Programme
Sheau W Lok, Richard De Boer, Cassandra Cordwell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2023
Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies
Adel Shahnam, Nadia Hitchen, Udit Nindra, et al.
Page
of 17